Antitumor activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium
Authors:
- Cirila DjordjevicCDCirila Djordjevic
- Galen L. WamplerGWGalen L. Wampler
- 1 September 1985
- journal article
- research article
- Published by Elsevier in Journal of Inorganic Biochemistry
- Vol. 25 (1) , 51-55
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Behavior of vanadate and vanadyl ion in canine bloodJournal of Inorganic Biochemistry, 1984
- Proton and 13C nuclear magnetic resonance studies of some yttrium and lanthanum complexes in aqueous solutionsJournal of the Less Common Metals, 1983
- Physiological and pharmacological properties of vanadiumLife Sciences, 1983
- The biochemistry of vanadium1983
- The National Cancer Chemotherapy ProgramScience, 1982
- The Essential Trace ElementsScience, 1981
- Peroxo- and hydroxolanthanide(III) complexes of the EDTA familyInorganic Chemistry, 1980
- Asymmetrically coordinated diperoxo compound. Crystal structure of tripotassium oxodiperoxooxalatovanadate(V) monohydrateInorganic Chemistry, 1975
- Oxodiperoxovanadate(V) complexes with bidentate ligandsJ. Chem. Soc., Dalton Trans., 1973
- Studies on Peroxovanadates. I. The Crystal Structure of Ammonium mu-Oxo-bis(oxodiperoxovanadate(V)), (NH4)4[O(VO(O2)2)2].Acta Chemica Scandinavica, 1971